News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- AstraZeneca’s confusing vaccine data, biotech in 2021, and a guide to the ASH conference
- CDC advisory panel’s lone dissenter on why long-term care residents shouldn’t receive Covid-19 vaccine first
- STAT+: With growing usage and few generics, Medicare spending on inhalers is climbing
- Public health experts are pressuring Biden to include health expertise in his Cabinet
- 4 storylines at the year's biggest meeting on blood diseases
- Israel’s OTV raises $170M for new digital health venture fund, plus China expansion
- US buys another 650,000 doses of Eli Lilly COVID-19 drug as outbreak surges
- COVID-19 vaccines based on novel platforms show early promise in mice
- As COVID demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50%
- 4D hires a trio of area heads as it ramps up its gene therapy pipeline
- LivaNova to exit heart valve business via €60M carve-out deal
- Not just AstraZeneca—North Korean hackers targeted 5 other COVID drug developers: WSJ
- STAT+: Pharmalittle: FDA’s Hahn defends Covid-19 vaccine vetting; U.K. denies cutting corners to approve Pfizer shot
- In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
- Anthony Fauci slams U.K.'s speedy review of Pfizer, BioNTech COVID shot